Vimarsana
Biggest News Aggregation in the World

Page 5 - Global Impression News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Global Impression. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Global Impression Today - Breaking & Trending Today

Lack of Evidence for Antidepressants in Treatment of Chronic Pain - Vimarsana News

Lack of Evidence for Antidepressants in Treatment of Chronic Pain

A new Cochrane review details the lack of evidence for antidepressants in the treatment of chronic pain.

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2023 Earnings Call Transcript - Vimarsana News

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2023 Earnings Call Transcript

Operator: Good morning and welcome to Intra-Cellular Therapies First Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Intra-Cellular Therapies Announces Positive Topline Results from Study 403 Evaluating Lumateperone as Monotherapy in Patients with Major Depressive Disorder with Mixed Features and Bipolar Depression with Mixed Features - Vimarsana News

Intra-Cellular Therapies Announces Positive Topline Results from Study 403 Evaluating Lumateperone as Monotherapy in Patients with Major Depressive Disorder with Mixed Features and Bipolar Depression with Mixed Features

Lumateperone 42mg was statistically significant on the primary endpoint of symptom reduction on the Montgomery Asberg Depression Rating Scale for each patient population including: -combined major... | March 28, 2023

Meditation is just as effective for anxiety as medication, study says - Vimarsana News

Meditation is just as effective for anxiety as medication, study says

A new study provides solid evidence that meditation is as effective as daily medication for those suffering anxiety disorder. Here's what to know.

Alopecia Update: Treatment and Link to Long COVID Explored - Vimarsana News

Alopecia Update: Treatment and Link to Long COVID Explored

Efficacy data on baricitinib and ritlecitinib in the treatment of alopecia, and research on alopecia as a common skin manifestation of long COVID presented at AAD 2022.